The international operation of Chinese pharmaceutical company, HUYA Bioscience International (HUYA) has expanded its Sen...
Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...
Daiichi Sankyo Company Limited has signed a license agreement with UK-based Cell Therapy Ltd for an exclusive license in...
Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...
Israel's Pluristem Therapeutics Inc. has announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has cl...
Singapore: ERT, a US-based service provider to biopharmaceutical organizations, medical device companies and contract re...
Based on a notification received from the Japanese Ministry of Health, Labour and Welfare, Daiichi Sankyo Company Limite...
Singapore: Otsuka Pharmaceutical reached an agreement to establish a joint venture (JV) in the functional food and bever...
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Th...
In a step to upgrade its pharmacovigilance services, Allergan Japan has announced that the company has implemented US-he...
Singapore: Teva Pharmaceutical and Takeda Pharmaceutical has announced that the two companies have entered into a defini...
Singapore: The global aortic stent grafts market will increase in value from an estimated $1.2 billion in 2013 to just o...
Singapore: With a view to expand into the lucrative Asian markets, two major medical companies in Japan have planned to ...
For the first time, Nihon University will organize an international symposium on Medical-Engineering Collaboration with ...
Physicians at 23 brain cancer centers in Japan are now certified to provide Optune to recurrent glioblastoma patients on...
Norway-based Serendex Pharmaceuticals A/S has entered into a non-binding term sheet with a pharma company regarding Sere...
Singapore: Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell di...
OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic diso...
